Press Releases
Celator® Pharmaceuticals Enrolls First Patient in Its Phase 3 Study of CPX-351 in Untreated High-Risk Acute Myeloid Leukemia
Celator Pharmaceuticals today announced that the first patient has been treated in its Phase 3, multicenter, randomized, open-label clinical trial of CPX-351 (cytarabine:daunorubicin) Liposome...
Press Releases
Wireless Physiological Monitoring System a Boon for Dialysis Patients
A wireless physiological monitoring system designed by the Department of Biomedical Engineering (BME) of National Cheng Kung University (NCKU), southern Taiwan, has proved to...
Press Releases
Oncodesign and the Laboratory for Neurobiology and Gene Therapy at the KU Leuven enter into a research collaboration for advancing drug discovery efforts with...
Oncodesign, a drug discovery company and oncology pharmacology service provider and the Laboratory for Neurobiology and Gene Therapy (LNGT) at the department of neurosciences...
Press Releases
Adaptimmune Announces Preliminary Results from an Early Phase Trial of Gene Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma
Adaptimmune today announces the release of preliminary results from an early phase clinical study using patients’ own T cells that have been genetically altered...
Press Releases
Quintiles Central Laboratory Receives First Industry Accreditation Dedicated to Biorepository Program
Quintiles today announced that its flagship central laboratory in the U.S. received accreditation from the College of American Pathologists (CAP) Biorepository Accreditation Program. The...
Press Releases
The launch of the first ever global Medical Science Liaison Society.
According to Dr. Samuel Dyer, Chairman of the Board of the MSL Society, “As the MSL role continues to rapidly grow and play an...
Press Releases
Nuron Biotech Acquires Commercial, Preventive Vaccine Meningitec™ from Pfizer
Nuron Biotech Inc., a specialty biologics and vaccines company, today announced it has acquired from Pfizer Inc. Meningitec™, which is a vaccine for the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.